These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12652181)

  • 1. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
    Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
    J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation.
    Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The zone of vulnerability to T wave shocks in humans.
    Swerdlow CD; Martin DJ; Kass RM; Davie S; Mandel WJ; Gang ES; Chen PS
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):145-54. PubMed ID: 9147699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators.
    Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantation of cardioverter defibrillators without induction of ventricular fibrillation.
    Swerdlow CD
    Circulation; 2001 May; 103(17):2159-64. PubMed ID: 11331256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test.
    Patel MB; Pandya K; Thakur RK
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper limit of vulnerability during defibrillator implantations predicts the occurrence of appropriate shock therapy for ventricular fibrillation.
    Yamashita S; Yoshida A; Fukuzawa K; Fujiwara R; Suzuki A; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hirata K
    Circ J; 2014; 78(7):1606-11. PubMed ID: 24817761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation.
    Ellenbogen KA; Wood MA; Gilligan DM; Crofts T; London W; McClish D
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):588-95. PubMed ID: 9654223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation.
    Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K; Lee K; Lau CP
    J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability.
    Swerdlow CD; Davie S; Ahern T; Chen PS
    Pacing Clin Electrophysiol; 1996 Dec; 19(12 Pt 1):2103-11. PubMed ID: 8994950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.